ID16921A - Komposisi untuk pengobatan sekali sehari terhadap penyakit-penyakit yang diperantarai siklooksigenase-2 - Google Patents

Komposisi untuk pengobatan sekali sehari terhadap penyakit-penyakit yang diperantarai siklooksigenase-2

Info

Publication number
ID16921A
ID16921A IDP971640A ID971640A ID16921A ID 16921 A ID16921 A ID 16921A ID P971640 A IDP971640 A ID P971640A ID 971640 A ID971640 A ID 971640A ID 16921 A ID16921 A ID 16921A
Authority
ID
Indonesia
Prior art keywords
cycloxigenase
composition
diseases related
against diseases
day treatment
Prior art date
Application number
IDP971640A
Other languages
English (en)
Indonesian (id)
Inventor
Bruno Hancock
Conrad Winters
Barry Gertz
Elliot Ehrich
Original Assignee
Merck & Co Inc
Merck Frosst Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26309472&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID16921(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9612063.9A external-priority patent/GB9612063D0/en
Application filed by Merck & Co Inc, Merck Frosst Canada Inc filed Critical Merck & Co Inc
Publication of ID16921A publication Critical patent/ID16921A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDP971640A 1996-05-17 1997-05-16 Komposisi untuk pengobatan sekali sehari terhadap penyakit-penyakit yang diperantarai siklooksigenase-2 ID16921A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1787896P 1996-05-17 1996-05-17
GBGB9612063.9A GB9612063D0 (en) 1996-06-10 1996-06-10 Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases

Publications (1)

Publication Number Publication Date
ID16921A true ID16921A (id) 1997-11-20

Family

ID=26309472

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP971640A ID16921A (id) 1996-05-17 1997-05-16 Komposisi untuk pengobatan sekali sehari terhadap penyakit-penyakit yang diperantarai siklooksigenase-2

Country Status (29)

Country Link
US (1) US6063811A (ko)
EP (1) EP0910368A1 (ko)
JP (1) JPH11512754A (ko)
KR (1) KR100373622B1 (ko)
CN (1) CN1140267C (ko)
AR (1) AR012014A1 (ko)
AU (1) AU3004997A (ko)
BG (1) BG103000A (ko)
BR (1) BR9709097A (ko)
CA (1) CA2254061C (ko)
CO (1) CO5050370A1 (ko)
CZ (1) CZ291463B6 (ko)
DZ (1) DZ2200A1 (ko)
EA (1) EA001596B1 (ko)
EE (1) EE03746B1 (ko)
HK (1) HK1021623A1 (ko)
HR (1) HRP970262A2 (ko)
HU (1) HUP9902889A3 (ko)
ID (1) ID16921A (ko)
IL (1) IL126899A (ko)
IS (1) IS4891A (ko)
MY (1) MY116201A (ko)
NO (1) NO985342L (ko)
NZ (1) NZ332670A (ko)
PE (1) PE66998A1 (ko)
PL (1) PL188649B1 (ko)
SK (1) SK284330B6 (ko)
TR (1) TR199802345T2 (ko)
WO (1) WO1997044028A1 (ko)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6136804A (en) * 1998-03-13 2000-10-24 Merck & Co., Inc. Combination therapy for treating, preventing, or reducing the risks associated with acute coronary ischemic syndrome and related conditions
WO1999045913A1 (en) * 1998-03-13 1999-09-16 Merck & Co., Inc. Combination therapy and composition for acute coronary ischemic syndrome and related conditions
SA99191255B1 (ar) * 1998-11-30 2006-11-25 جي دي سيرل اند كو مركبات سيليكوكسيب celecoxib
CO5190664A1 (es) 1999-06-30 2002-08-29 Pfizer Prod Inc Terapia de combinacion para el tratamiento de migrana administracion de un receptor 5ht, cafeina y un inhibidor de ciclooxigenasa-2
GB9920558D0 (en) * 1999-08-31 1999-11-03 Bradford Particle Design Ltd Methods for particle formation and their products
NZ519466A (en) * 1999-12-22 2004-02-27 Pharmacia Corp Sustained-release formulation of a cyclooxygenase-2 inhibitor
PL206268B1 (pl) 2000-06-13 2010-07-30 Wyethwyeth Kompozycja przeciwbólowa i/lub przeciwzapalna oraz jej zastosowanie
CN1638739A (zh) * 2000-08-18 2005-07-13 法玛西雅厄普约翰美国公司 治疗成瘾性障碍的化合物
ATE329583T1 (de) * 2000-08-18 2006-07-15 Pharmacia Corp Schnell zerfallende orale arzneizubereitung enthaltend valdecoxib
AU2001285334A1 (en) * 2000-08-29 2002-03-13 Peter Van Patten Combination for the treatment of migraine comprising a cyclooxygenase-2 inhibitor and acetylsalicylic acid
PE20020351A1 (es) * 2000-09-11 2002-06-14 Novartis Ag Composiciones farmaceuticas que comprenden acido 5-metil-2-(2'-cloro-6'-fluoroanilino)fenilacetico como inhibidor de la ciclooxigenasa-2
US7115565B2 (en) * 2001-01-18 2006-10-03 Pharmacia & Upjohn Company Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
EP1423114A4 (en) * 2001-05-04 2006-05-17 Merck & Co Inc METHOD AND COMPOSITIONS FOR TREATING MIGRAINE
PE20030323A1 (es) * 2001-08-31 2003-05-12 Novartis Ag Composicion farmaceutica
GEP20063856B (en) * 2001-09-26 2006-06-26 Pharmacia Corp Organoleptically acceptable intraorally disintegrating compositions
CA2462881A1 (en) * 2001-10-10 2003-04-17 Pharmacia Corporation Intraorally disintegrating valdecoxib compositions prepared by spray drying process
AU2003227039B2 (en) * 2002-03-07 2007-04-19 Novartis Ag Pharmaceutical compositions
ES2213485B1 (es) 2003-02-13 2005-12-16 Almirall Prodesfarma, S.A. Derivados de la 2-fenilpiran-4-ona.
ES2214129B1 (es) * 2003-02-13 2005-12-01 Almirall Prodesfarma, S.A. 3-fenilfuran-2-onas.
ES2275218T3 (es) 2003-05-07 2007-06-01 Osteologix A/S Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos.
TR200301552A1 (tr) * 2003-09-18 2005-10-21 Nobel İlaç Sanayi̇ Ve Ti̇caret A. Ş. Rofekoksib' in yeni oral farmakolojik formülasyonları.
CN101626787A (zh) * 2007-01-19 2010-01-13 马林克罗特公司 诊断的和治疗的环氧合酶-2结合配体
CN113660934A (zh) 2018-11-21 2021-11-16 特默罗制药股份有限公司 罗非昔布的纯化形式、制备方法和用途
WO2020210341A1 (en) * 2019-04-09 2020-10-15 Tremeau Pharmaceuticals, Inc. Treatment of viral hemorrhagic fevers with cox-2 selective non-steroidal antiinflammatory drugs
US10945992B1 (en) 2019-11-13 2021-03-16 Tremeau Pharmaceuticals, Inc. Dosage forms of rofecoxib and related methods
US11161833B1 (en) 2021-04-09 2021-11-02 Tremeau Pharmaceuticals, Inc. Deuterated etoricoxib, methods of manufacture, and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
HUT74986A (en) * 1994-01-10 1997-03-28 Merck Frosst Canada Inc Phenyl heterocycles as cox-2 inhibitors, pharmaceutical preparations containing them, and use of them

Also Published As

Publication number Publication date
HUP9902889A3 (en) 2002-04-29
MY116201A (en) 2003-11-28
CN1140267C (zh) 2004-03-03
EP0910368A1 (en) 1999-04-28
SK284330B6 (sk) 2005-01-03
NZ332670A (en) 2000-07-28
KR20000011082A (ko) 2000-02-25
CA2254061A1 (en) 1997-11-27
IL126899A (en) 2004-03-28
JPH11512754A (ja) 1999-11-02
CN1225010A (zh) 1999-08-04
CZ291463B6 (cs) 2003-03-12
EA001596B1 (ru) 2001-06-25
EA199801017A1 (ru) 1999-04-29
HRP970262A2 (en) 1998-06-30
NO985342D0 (no) 1998-11-16
PL329940A1 (en) 1999-04-26
IL126899A0 (en) 1999-09-22
EE03746B1 (et) 2002-06-17
CZ373898A3 (cs) 1999-06-16
AR012014A1 (es) 2000-09-27
PE66998A1 (es) 1998-10-24
AU3004997A (en) 1997-12-09
SK156798A3 (en) 2000-01-18
DZ2200A1 (fr) 2004-06-20
BR9709097A (pt) 1999-08-03
KR100373622B1 (ko) 2003-07-12
CA2254061C (en) 2003-12-02
WO1997044028A1 (en) 1997-11-27
PL188649B1 (pl) 2005-03-31
BG103000A (en) 1999-09-30
HK1021623A1 (en) 2000-06-23
CO5050370A1 (es) 2001-06-27
HUP9902889A2 (hu) 2002-01-28
NO985342L (no) 1998-11-16
EE9800393A (et) 1999-06-15
TR199802345T2 (xx) 1999-03-22
US6063811A (en) 2000-05-16
IS4891A (is) 1998-11-10

Similar Documents

Publication Publication Date Title
ID16921A (id) Komposisi untuk pengobatan sekali sehari terhadap penyakit-penyakit yang diperantarai siklooksigenase-2
DK0769017T3 (da) Terapeutiske forbindelser
ATE192157T1 (de) Therapeutisch verwendbare spiro-azabicyclische verbindungen
DE69618854D1 (de) Fotopolymerisierbare Zusammensetzung
ID18168A (id) Mekanisma pengatur waktu katup bervariasi mesin
DE69520639D1 (de) Desinfizierende Zusammensetzung
BR9605176A (pt) Composição fotocurável
DE69626993T2 (de) Wundbehandlungszusammensetzung
DE69521039D1 (de) Gewebeweichmacherzusammensetzung
BR9607925A (pt) Composição fungicida
DE69604601D1 (de) Fotopolymerisierbare Zusammensetzung
DE69503738D1 (de) Fotopolymerisierbare Zusammensetzung
DE69505358D1 (de) Gewebeweichmacherzusammensetzung
ID17723A (id) Senyawa untuk pengobatan
EP0944635A4 (en) THERAPEUTIC DIPHOSPHONATE COMPOUNDS
NO983090D0 (no) Terapeutiske forbindelser
FI971447A0 (fi) Venttiili käsienpesuallasta varten
BR9607487A (pt) Composição herbicida
HUP0000954A3 (en) Medicinal compositions for treating cardiac diseases caused by cardiac hypertrophy
BR9503633A (pt) Composição desinfetante
BR9610382A (pt) Composição de tratamento do cableo
HU9801925D0 (en) Sodium-hydrogen-change-inhibitors for producing pharmaceutical compositions for treating diseases caused by protozoons
DE69508069D1 (de) Gewebeweichnacherzusammensetzung
DE69605584D1 (de) Fotopolymerisierbare Zusammensetzung
IT1274783B (it) Preparato per il trattamento dell'obesita'